About this Series
Therapies to prevent and treat osteoporosis in postmenopausal women have been widely used for several decades, yet osteoporotic fractures in this population continue to impose a growing burden on patients, their families, and the healthcare system. Thirty percent of all postmenopausal women in the United States and Europe have osteoporosis. The lifetime risk for fracture for a 60-year-old woman is estimated to be around 44%.
Cost-effective treatments to reduce fracture risk are available, but only 23% of women age 67 or older who have an osteoporosis-related fracture receive either a bone mineral density (BMD) test or a prescription for an osteoporosis treatment. Meanwhile, the use of oral and intravenous bisphosphates has continued on a downward trend due in part to news coverage of safety concerns.
In this series, Pauline Camacho, MD, a leading endocrinologist from Loyola University Chicago, and Jessica Starr, MD, from the Hospital for Special Surgery in New York City discuss the need for thorough assessment of postmenopausal fracture risk and emphasizes the importance of early intervention to reduce fracture, including optimal pharmacologic and nonpharmacologic approaches, especially in high-risk patients.
Cost-effective treatments to reduce fracture risk are available, but only 23% of women age 67 or older who have an osteoporosis-related fracture receive either a bone mineral density (BMD) test or a prescription for an osteoporosis treatment. Meanwhile, the use of oral and intravenous bisphosphates has continued on a downward trend due in part to news coverage of safety concerns.
In this series, Pauline Camacho, MD, a leading endocrinologist from Loyola University Chicago, and Jessica Starr, MD, from the Hospital for Special Surgery in New York City discuss the need for thorough assessment of postmenopausal fracture risk and emphasizes the importance of early intervention to reduce fracture, including optimal pharmacologic and nonpharmacologic approaches, especially in high-risk patients.
.png)
No hay comentarios:
Publicar un comentario